Diality

Overview
News
Next-gen Medical Devices?
Product stageSegments
Minimum Viable Product
?
Other non-surgical devices
?

Diality Inc. is a medical technology company based in Irvine, California, that has developed the Moda-flx Hemodialysis System, a versatile and mobile hemodialysis device. The system offers a wide range of prescription options, from low-dose extended treatments to high-dose in-center treatments, catering to the diverse needs of dialysis patients. Diality's hemodialysis system achieves the same flow rates as in-center systems, where approximately 85% of treatments are currently performed.

The Moda-flx system is designed to be user-friendly for both professional staff and patients or caregivers, enabling its use in various healthcare settings, including hospitals, skilled nursing facilities, and dialysis centers. The system's flexibility allows kidney care providers to choose the most appropriate prescription for their patients and practices as the market evolves toward delivering dialysis in a broader range of settings.

In addition to its versatility, the Moda-flx system boasts the ability to achieve dialysate flow rates up to twice those of its competitors, enabling fewer treatments per week or shorter treatment times while achieving standard dialysis efficacy metrics more efficiently than existing devices in the category. This feature is particularly significant given the total addressable market for Diality's hemodialysis system, estimated to be over USD 7 billion in the US alone.

In preparation for the commercial launch of the Moda-flx system, Diality has partnered with Paramit Corporation, a medical device manufacturer, to manufacture the capital components of the innovative hemodialysis system. This partnership aims to accelerate the commercialization effort and leverage Paramit's expertise in complex electromechanical and fluidic systems, including hemodialysis machines.


Sources

Disclaimer: This company profile has been generated using data obtained through automated web searches and advanced generative AI technology. While we strive to ensure the accuracy and reliability of our sources, auto-generated information could be outdated or inaccurate and should be verified independently.
HQ location:
181 Technology Drive Suite 150 Irvine CA USA
Founded year:
2013
Employees:
11-50
IPO status:
Private
Total funding:
USD 82.5 mn
Last Funding:
USD 28.0 mn (Series C; Aug 2023)
Last valuation:
-
Key competitors
Filter by the segments to which the disruptor belongs
All Segmentsexpand
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.